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qq This manuscript has not been presented at any meeting.Anisha Seth ⇑; Basudeb Ghosh; Anika Gupta; Neha GoelAbstractNeurofibromatosis type 1 (NF-1) is an autosomal dominantly inherited disease characterized by café-au-lait spots, neurofibromas,
axillary freckling, Lisch nodules of iris, gliomas and various systemic vascular ischemic manifestations mainly in the aorta, brain and
kidney. Retinal vascular manifestations in patients with NF-1 are usually representative of retinal capillary hemangiomatosis. Few
cases of NF-1 with retinal vascular occlusive disease have been described. We describe a young Indian woman with NF-1 with
unilateral peripheral retinal ischemia but no vascular abnormality at the posterior pole.
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http://dx.doi.org/10.1016/j.sjopt.2015.08.005IntroductionNeurofibromatosis type 1 (NF-1) is an autosomal domi-
nantly inherited disease characterized by café-au-lait spots,
neurofibromas, axillary freckling, Lisch nodules of iris, glio-
mas and various systemic vascular ischemic manifestations
mainly in the aorta, brain and kidney.1,2 The gene responsible
for this condition, NF1, has been isolated to chromosomal
region 17q11.2 and is a tumor-suppressor gene. Its gene
product, neurofibromin has a domain homologous to the
GTPase activating protein (GAP) family, and downregulates
RAS activity and consequently controls cell proliferation.
The loss of neurofibromin expression in NF-1 leads to
increased RAS activity, which initiates the process of tumor
formation in various parts of the body.3
Ocular manifestations in NF-1 are plexiform neurofibromas
of the eyelids, Lisch nodules of the iris, congenital glaucoma,
optic glioma, retinal astrocytic hamartomas, retinal capillary
hemangiomas and microvascular retinal abnormalities.4,5Retinal vascular manifestations in patients with NF-1 are usually
representative of retinal capillary hemangiomatosis.4 Few cases
with retinal vascular occlusive disease have been described.6–9
Two cases with peripheral retinal ischemia and neovascular
glaucoma have also been recently described.10,11 We describe
a young Indian woman with NF-1 with unilateral peripheral
retinal ischemia and an unremarkable posterior pole.
Case report
A 26 years old female, a known case of neurofibromatosis
type 1, presented with floaters in both eyes for one month
and pain in central abdomen for 2 weeks. She had history
of use of myopic glasses in both eyes (10 DS) since 15 years
and history of retinal detachment surgery in left eye 10 years
back. The diagnosis of NF-1 was made in childhood, on the
basis of physical findings such as multiple café-au-lait spots
and neurofibromas throughout the body, axillary freckling
and three first-degree relatives with NF-1. She was born at
full term with a birth weight of 2500 g.e:
al.com
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physical examination of the patient was unremarkable. Her
best corrected visual acuity (BCVA) in the right eye was
20/20 and the left eye was 20/100. The anterior chamber
was within normal limits in both eyes and the iris did not show
any Lisch nodules or neovascularization. Her intraocular pres-
sure (IOP) by Goldmann applanation tonometry was 18 mm
of mercury in both eyes. On fundus examination in the right
eye, the disk and macula were normal. There was mild venous
dilatation at the posterior pole and multiple sclerosed vessels
in the periphery (Fig. 2a). The left eye fundus showed an
attached retina with 360 encirclage indent with dispersed
pigmentation throughout, with subretinal fibrosis passing
through the macula, probably suggestive of resolved retinal
detachment (Fig. 2a). Both eyes did not have any peripheral
treatable lesions.
The fundus fluorescein angiography of both eyes showed
a normal arm-retina time with normal filling of all vessels.
The right eye showed peripheral capillary non-perfusion
(CNP) areas temporally and inferiorly without any macular
leakage or neovascularization of the disk or elsewhere
(NVD/NVE) (Fig. 3a). The FFA of the left eye did not show
any capillary non-perfusion areas (Fig. 3b). Spectral-domain
optical coherence tomography (SD-OCT) showed normal
fovea in the right eye (Fig. 4a) and foveal thinning in the left
eye (Fig. 4b).
The patient had a normal blood pressure and all other
laboratory investigations such as blood sugar, complete
blood count, coagulation profile, chest X-ray, Mantoux test,
rheumatoid factor and anti-nuclear antibody done to ruleFigure 1. Showing (a) cafe au lait spots, (b) axillary freckling, (c) neurofibromaout other causes of vascular occlusive disorder were found
to be within normal limits. Non-invasive Doppler flow study
of carotid arteries did not show any stenosis.
The patient underwent sectoral pan-retinal photocoagula-
tion in the right eye and was subsequently referred to the
department of surgery for abdominal pain, where an ultra-
sonography of abdomen was done that showed a right sided
paravertebral lesion, 10 cm  6 cm in size, abutting the liver
and causing mass effect. Following this, an MRI (brain and
spine) was done that revealed a dumb-bell shaped mass
lesion in right paraspinal region at D10 level suggestive of
a Nerve-Sheath tumor/neurofibroma (Fig. 1d).
At 1 year follow-up, the patient has maintained the same
BCVA and does not exhibit any fibrovascular proliferation in
the right eye fundus.Discussion
Systemic vascular occlusion disease has been previously
reported in NF-1 to affect aortic, cerebral, renal, celiac and
mesenteric vessels.2 The occlusive manifestations include
stenosis of small vessels, progressive capillary ischemia and
compensatory collateral circulation.
The pathogenesis of vascular occlusion is related to the
growth of Schwann cells and dysplasia of arteriolar smooth
muscle cells, which leads to a progressive narrowing of the
vessel and consequent occlusion with secondary fibrous
changes.2 Ozerdem described NF-1 gene mutations as a
cause of increased proliferation of pericytes and endothelials, and (d) MRI spine showing plexiform neurofibroma at the level of D10.
Figure 3. (a) Fluorescein angiography of right eye few window defects at the posterior pole with peripheral capillary non-perfusion (CNP) areas
temporally and inferiorly (red arrow). (b) Fluorescein angiography of the left eye showing blocked fluorescence due to pigmentation without any
peripheral capillary non-perfusion (CNP) areas.
Figure 2. (a) Fundus photograph of the right eye showing mild venous dilatation at the posterior pole and multiple sclerosed vessels in the periphery
(red arrow). (b) Fundus photograph of the left eye showing dispersed pigmentation throughout, with subretinal fibrotic band passing through the macula
(blue arrow) with encirclage indent (red arrow).
Figure 4. (a) SD-OCT of right eye showing a normal scan; (b) SD-OCT of left eye showing foveal thinning.
62 A. Seth et al.cells that enhance the angiogenic response of the retina to
the ischemia.12 Moreover, loss of neurofibromin expression
in endothelial cells is also considered to affect the interac-
tions between endothelial cells and pericytes with a conse-quently abnormal proliferation of both these cells and final
vascular occlusion.11,12
In a chronic and slowly progressive vascular inadequacy,
the veins get accustomed to the vascular disturbance.
Peripheral retinal ischemia in Neurofibromatosis-1 63Especially in young patients, the venous system compensates
well, leading to silent occlusions which might not present till
late in life.7
Our patient had all the physical features of NF-1 along
with peripheral vascular occlusions in one eye only. The
mechanism of this unilaterality is not fully understood but is
reported in other organs too, such as the kidney, brain and
large vessels of the heart and is recognized as a characteristic
feature of ischemia in NF-1. All other causes of peripheral
retinal ischemia in this young woman were ruled out by his-
tory and laboratory tests.
Four cases of NF-1 with retinal vascular occlusive disorder
have been described and all were unilateral. Three of them
had a diffuse involvement with both major and peripheral
vessels showing occlusion,6–8 while one showed only macular
artery involvement.9 Two patients presenting with neovascu-
lar glaucoma have been described as well.10,11 However, to
the best of our knowledge, no case has been described with
involvement of only peripheral vasculature while the major
vessels are spared.
We also recommend detailed fundus examination of all
patients with NF-1 to rule out vascular occlusions. Further-
more, NF-1 should be considered in the differential diagnosis
of retinal vascular occlusive disease in young patients without
any other risk factors.
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